Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy

Free Radical Biology and Medicine

Volumn 87, Issue , 2015, Pages 263-273

  Umbarkar, Prachi ^a   Singh, Sarojini ^a   Arkat, Silpa ^a   Bodhankar, S L ^b   Lohidasan, Sathiyanarayanan ^b   Sitasawad, Sandhya L ^a  

^a UNIVERSITY OF PUNE   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Apoptosis; Cardiac dy sfunction; Diabetic cardiomyopathy; Freeradicals; Monoamine oxidase A; Oxidativestress

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE 9; CATECHOLAMINE; CLORGYLINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TROPONIN I; UNCOUPLING PROTEIN 3; AMINE OXIDASE (FLAVIN CONTAINING); ANTIOXIDANT; MONOAMINE OXIDASE INHIBITOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CATHETER TIP TRANSDUCER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME INDUCTION; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMIC PARAMETERS; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIPID PEROXIDATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QRS INTERVAL; QT INTERVAL; QTC INTERVAL; RAT; REDOX STRESS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CARDIAC MUSCLE; COMPLICATION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FIBROSIS; GENETICS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; METABOLISM; PATHOLOGY;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CLORGYLINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; FIBROSIS; HUMANS; LIPID PEROXIDATION; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84940373910     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.025     Document Type: Article

References (42)

1. I.G. Poornima, P. Parikh, and R.P. Shannon Diabetic cardiomyopathy: the search for a unifying hypothesis Circ. Res. 98 2006 596 605
2. B. Swynghedauw Molecular mechanisms of myocardial remodeling Physiol. Rev. 79 1999 215 262
3. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
4. Y. Chen, J.T. Saari, and Y.J. Kang Weak antioxidant defenses make the heart a target for damage in copper-deficient rats Free Radic. Biol. Med. 17 1994 529 536
5. S. Kumar, S. Prasad, and S.L. Sitasawad Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats PLoS One 8 2013 e67009
6. Z. Guo, Z. Xia, J. Jiang, and J.H. McNeill Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine Am. J. Physiol. Heart Circ. Physiol 292 2007 H1728 H1736
7. L. Cai, Y. Wang, G. Zhou, T. Chen, Y. Song, X. Li, and et al. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy J. Am. Coll. Cardiol. 48 2006 1688 1697
8. P. Rosen, T. Ballhausen, W. Bloch, and K. Addicks Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant Diabetologia 38 1995 1157 1168
9. N. Kaludercic, A. Carpi, R. Menabo, L.F. Di, and N. Paolocci Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury Biochim. Biophys. Acta 1813 2011 1323 1332
10. N. Kaludercic, E. Takimoto, T. Nagayama, N. Feng, E.W. Lai, D. Bedja, and et al. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload Circ. Res. 106 2010 193 202
11. C. Villeneuve, C. Guilbeau-Frugier, P. Sicard, O. Lairez, C. Ordener, T. Duparc, and et al. p53-PGC-1alpha pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-A upregulation: role in chronic left ventricular dysfunction in mice Antioxid. Redox Signaling 18 2013 5 18
12. A. Carpi, R. Menabo, N. Kaludercic, P. Pelicci, L.F. Di, and M. Giorgio The cardioprotective effects elicited by p66 (Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury Biochim. Biophys. Acta 1787 2009 774 780
13. P. Bianchi, O. Kunduzova, E. Masini, C. Cambon, D. Bani, L. Raimondi, and et al. Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and post ischemic myocardial injury Circulation 112 2005 3297 3305
14. D. Pchejetski, O. Kunduzova, A. Dayon, D. Calise, M.H. Seguelas, N. Leducq, and et al. Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis Circ. Res. 100 2007 41 49
15. C.A. Maggi, and A. Meli Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2. Cardiovascular system Experientia 42 1986 292 297
16. K.S. Heffernan, S.Y. Jae, and B. Fernhall Heart rate recovery after exercise is associated with resting QTc interval in young men Clin. Auton. Res. 17 2007 356 363
17. Y.K. Gupta, M. Sharma, and G. Chaudhary Pyrogallol-induced hepatotoxicity in rats: a model to evaluate antioxidant hepatoprotective agents Methods Find. Exp. Clin. Pharmacol. 24 2002 497 500
18. D. Grotto, L.D. Santa Maria, S. Boeira, J. Valentini, M.F. Charao, A.M. Moro, and et al. Rapid quantification of malondialdehyde in plasma by high performance liquid chromatography-visible detection J. Pharm. Biomed. Anal. 43 2007 619 624
19. M.K. Lakshmana, and T.R. Raju An isocratic assay for norepinephrine, dopamine, and 5-hydroxytryptamine using their native fluorescence by high-performance liquid chromatography with fluorescence detection in discrete brain areas of rat Anal. Biochem. 246 1997 166 170
20. M. Zhou, and N. Panchuk-Voloshina A one-step fluorometric method for the continuous measurement of monoamine oxidase activity Anal. Biochem. 253 1997 169 174
21. J.P. Jacobsen, W.B. Siesser, B.D. Sachs, S. Peterson, M.J. Cools, V. Setola, and et al. Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice Mol. Psychiatry 17 2012 694 704
22. Y. Zhang, S.A. Babcock, N. Hu, J.R. Maris, H. Wang, and J. Ren Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3beta and mitochondrial function BMC Med. 10 2012 40
23. G. Zhou, X. Li, D.W. Hein, X. Xiang, J.P. Marshall, S.D. Prabhu, and et al. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart J. Am. Coll. Cardiol. 52 2008 655 666
24. L. Cai, W. Li, G. Wang, L. Guo, Y. Jiang, and Y.J. Kang Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway Diabetes 51 2002 1938 1948
25. J.C. Reed Bcl-2 and the regulation of programmed cell death J. Cell Biol. 124 1994 1 6
26. R.M. Kluck, E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Science 275 1997 1132 1136
27. J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, and et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked Science 275 1997 1129 1132
28. D.R. Green, and J.C. Reed Mitochondria and apoptosis Science 281 1998 1309 1312
29. L. Cai, and Y.J. Kang Oxidative stress and diabetic cardiomyopathy: a brief review Cardiovasc. Toxicol. 1 2001 181 193
30. Z.V. Varga, Z. Giricz, L. Liaudet, G. Hasko, P. Ferdinandy, and P. Pacher Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy Biochim. Biophys. Acta 1852 2015 232 242
31. D.C. Raev Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients Diabetes Care 17 1994 633 639
32. C.M. Schannwell, M. Schneppenheim, S. Perings, G. Plehn, and B.E. Strauer Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy Cardiology 98 2002 33 39
33. M.L. Weisfeldt, H.E. Scully, J. Frederiksen, J.J. Rubenstein, G.M. Pohost, E. Beierholm, and et al. Hemodynamic determinants of maximum negative dP-dt and periods of diastole Am. J. Physiol. 227 1974 613 621
34. M. Slama, J. Ahn, M. Peltier, J. Maizel, D. Chemla, J. Varagic, and et al. Validation of echocardiographic and Doppler indexes of left ventricular relaxation in adult hypertensive and normotensive rats Am. J. Physiol. Heart Circ. Physiol 289 2005 H1131 H1136
35. C. Grousset, P. Menasche, C.S. Apstein, C. Mouas, F. Marotte, and A. Piwnica Protective effects of cardioplegia on diastolic function of hypertrophied rat hearts after hypothermic ischaemic arrest Eur. Heart J. 5 Suppl. F 1984 347 353
36. T. Ogata, T. Miyauchi, S. Sakai, M. Takanashi, Y. Irukayama-Tomobe, and I. Yamaguchi Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway J. Am. Coll. Cardiol. 43 2004 1481 1488
37. K. Mizushige, L. Yao, T. Noma, H. Kiyomoto, Y. Yu, N. Hosomi, K. Ohmori, and H. Matsuo Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model Circulation 101 2000 899 907
38. S. Stern, and S. Sclarowsky The ECG in diabetes mellitus Circulation 120 2009 1633 1636
39. F.C. Howarth, M. Jacobson, O. Naseer, and E. Adeghate Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats Exp. Physiol. 90 2005 237 245
40. P.K. Christensen, M.A. Gall, A. Major-Pedersen, A. Sato, P. Rossing, L. Breum, and et al. QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes Scand. J. Clin. Lab. Invest. 60 2000 323 332
41. C.R. Cardoso, G.F. Salles, and W. Deccache QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus Stroke 34 2003 2187 2194
42. S.L. Badole, G.B. Jangam, S.M. Chaudhari, A.E. Ghule, and A.A. Zanwar L-Glutamine supplementation prevents the development of experimental diabetic cardiomyopathy in streptozotocin-nicotinamide induced diabetic rats PLoS One 9 2014 e92697